DOR BioPharma and Cambrex Achieve Milestone in the Development and Manufacture of RiVax MIAMI and EAST RUTHERFORD, N.J., July 20, 2005 (PRIMEZONE) -- DOR BioPharma, Inc. (AMEX:DOR) ("DOR", or the "Company") and a subsidiary of Cambrex Corporation (NYSE:CBM) today announced that they...